Securing £3.1m in series A financing allows us to complete our product development and implement US and European regulatory strategies. Talk to us about why we’re confident of success in a $2.5bn market.
SIRAKOSS is a medical device company based in Scotland. We have developed synthetic bone graft substitutes that will revolutionize the treatment of bone defects and fusions. Incorporated in 2010, we have produced a portfolio of award winning technologies that have demonstrated outstanding performance in established pre-clinical models of trauma and spinal fusion.
We have a well defined international distribution strategy. Contact us for a Distributors’ Assessment form.
A core principle is excellence in people. We are a highly motivated, focussed team intent on delivering improvements in quality of patient care through innovative thinking. Join us and help drive our vision forward.
Are you looking to invest, distribute or collaborate with us?
If yes, click get in touch to be taken to our short message form and relay your intent.
There are no current positions available.
Please check back in future, or send us your CV, using the form opposite in a speculative basis.